4//SEC Filing
Jafri Hasan 4
Accession 0001493152-22-034683
CIK 0001614067other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 9:00 AM ET
Size
5.5 KB
Accession
0001493152-22-034683
Insider Transaction Report
Form 4
Jafri Hasan
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2022-12-05+20,000→ 20,000 total→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]10,000 shares of Common Stock will vest on June 5, 2023 and 10,000 will vest on 12/5/2023. In the event that the Reporting Person's employment is terminated without cause by the Issuer, the RSUs will immediately vest.
Documents
Issuer
Aridis Pharmaceuticals, Inc.
CIK 0001614067
Entity typeother
Related Parties
1- filerCIK 0001815352
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 9:00 AM ET
- Size
- 5.5 KB